Central Venous Catheterization News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer(R) System Procedure
CMS creates new billing code and new technology APC assignment for the insertion of central venous catheter using a reverse central venous recanalization device, with fluoroscopic image guidance SAN ANTONIO, Sept. 20, 2021 -- (Healthcare Sales & Marketi... Devices, Reimbursement Bluegrass Vascular Technologies, Surfacer System, Inside-Out Access Catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 20, 2021 Category: Pharmaceuticals Source Type: news

Ultrasound-guided vein access safe, quick in kids
Ultrasound-guided tunneled central venous access proved safe for children in...Read more on AuntMinnie.comRelated Reading: Interventional radiology to grow after COVID-19 subsides Interventional radiology comes into its own Ultrasound: The 60-year-old modality of the future POCUS provides unique advantages for COVID-19 imaging The value of PICC for interventional radiologists (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 4, 2021 Category: Radiology Source Type: news

ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections. Medtech innovation briefing [MIB234]
The technology described in this briefing is ClearGuard HD Antimicrobial Barrier Cap. It is a central venous catheter cap with chlorhexidine acetate coated rod and cap threads, used to help prevent catheter-related bloodstream infections in people having haemodialysis.The innovative aspects are that it could replace the need to clean the connector port with 2% chlorhexidine in 70% alcohol and potentially reduce the risk of catheter-related bloodstream infections.The intended place in therapy would be as an alternative to using standard central venous catheter caps in people having dialysis.The main points from the evidence...
Source: Current Awareness Service for Health (CASH) - November 19, 2020 Category: Consumer Health News Source Type: news

Antibiotic Administration Prior to Central Venous Catheter Removal in Neonates
Conclusion(s): Administration of one-time doses of vancomycin and cefazolin did not reduce the incidence of PCRCS when administered to critically ill neonates prior to umbilical venous catheter or peripherally inserted central catheter removal. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

Family integrated care in single family rooms for preterm infants and late-onset sepsis: a retrospective study and mediation analysis
Conclusion(s): SFRs were associated with decreased incidences of LOS and shorter length of hospital stay. The positive effect of SFRs on LOS was mainly mediated through a decreased use of PN in SFRs. Impact: Family integrated care (FICare) in single family rooms for preterm infants was associated with less late-onset sepsis events during hospital stay and a shorter length of hospital stay after birth.FICare in single family rooms was associated with less use of peripheral or central venous catheters and parenteral nutrition.Mediation analysis provided insights into the mechanisms underlying the effect of FICare in single f...
Source: Current Awareness Service for Health (CASH) - May 6, 2020 Category: Consumer Health News Source Type: news

FDA Grants De Novo Clearance to Bluegrass Vascular Technologies for the Surfacer(R) Inside-Out(R) Access Catheter System
First device to reliably and repeatedly achieve central venous access from the inside-out in patients with venous obstructions SAN ANTONIO, Feb. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Bluegrass Vascular Technologies (Bluegrass Vascular),... Devices, FDA Bluegrass Vascular Technologies, Surfacer System, Surfacer Inside-Out (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Risk for Blood Clots Increased With PICC Placement in Children
TUESDAY, Jan. 7, 2020 -- Central venous catheter (CVC) placement with peripherally inserted central catheters (PICCs) in children is associated with increased risks for venous thromboembolism (VTE), central line-associated bloodstream infection... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 7, 2020 Category: Pharmaceuticals Source Type: news

Thrombolysis Effective for Treating Occluded Central Venous Catheters in Kids Thrombolysis Effective for Treating Occluded Central Venous Catheters in Kids
Thrombolysis, particularly with alteplase, appears to be effective and likely safe for treating occluded central venous catheters in children with cancer, according to a meta-analysis.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 10, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

AI Beats Out Clinicians in Triaging Postoperative Patients for ICU
How good is artificial intelligence in decision-making? Not bad according to findings from a pilot study that was recently presented at the American College of Surgeons Clinical Congress 2019. Findings from the study show AI in the form of a machine-learned algorithm correctly triaged the vast majority of postoperative patients to the intensive care unit in its first proof-of-concept application in a university hospital setting. As it stands now surgical teams typically rely on clinical judgment to decide which patients need postoperative intense care because there is no single set of fixed criteria to make the determinati...
Source: MDDI - October 30, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Digital Health Source Type: news

What Are Pulmonary Embolism Risk Factors?
Discussion Pulmonary embolism (PE) is potentially life-threatening but fortunately rare event especially in the pediatric population. It was first described in children in 1861. PE is likely underreported because of minimal or non-specific clinical symptoms. The incidence is estimated at 0.05-4.2% with the 4.2% based on autopsy reports. It is probably also increasing as more central venous catheters (CVC) are used, and more children are surviving previously poor prognostic diseases. There is a bimodal distribution with cases < 1 year (especially neonates which account for ~50% of this group) and in teenagers. Neonates a...
Source: PediatricEducation.org - September 23, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Antimicrobial central venous catheters do not reduce infections in pre-term babies
Expert commentary states CVCs impregnated with antimicrobials (n=430) are no better than standard CVCs (n=431). Time from allocation to first bloodstream infection was similar (HR 1.11, p=0 · 63) and 46/430 (10%) or 44/431 (11%) babies developed bloodstream infection, respectively. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 27, 2019 Category: Consumer Health News Source Type: news

Candida Bloodstream Infections Among Persons with Injection Drug Use --- Denver Metropolitan Area, Colorado, 2017--2018
Candidemia, a bloodstream infection caused by Candida species, is typically considered a health care-associated infection, with known risk factors including the presence of a central venous catheter, receipt of total parenteral nutrition or broad-spectrum antibiotics, recent abdominal surgery, admission to an intensive care unit, and prolonged hospitalization. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 28, 2019 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Candida Source Type: news

St. Paul firm pursuing easier hemodialysis treatments closes on nearly $6 million round
St. Paul-based Phraxis Inc.'s device offers an alternative to a central venous catheter. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 13, 2019 Category: American Health Authors: Alex Wittenberg Source Type: news

St. Paul firm pursuing easier hemodialysis treatments closes on nearly $6 million round
St. Paul-based Phraxis Inc.'s device offers an alternative to a central venous catheter. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 13, 2019 Category: Biotechnology Authors: Alex Wittenberg Source Type: news

Results of ABATE infection trial published
(Harvard Pilgrim Health Care Institute) Daily bathing with an antiseptic soap, plus nasal ointment for patients with prior antibiotic resistant bacteria, reduced hospital acquired infections among patients with central venous catheters and other devices that pierce the skin, according to results of the ABATE Infection Trial. The study, " Chlorhexidine versus Routine Bathing to Prevent Multi Drug-Resistant Organisms and All-Cause Bloodstream Infection in General Medical and Surgical Units: The ABATE Infection Cluster Randomized Trial, " was published March 5 in The Lancet, Online. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 5, 2019 Category: Infectious Diseases Source Type: news